CCP
MET icon

Corient Capital Partners’s MetLife MET Stock Holding History

Corient Capital Partners’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.29M Buy
20,479
+942
+5% +$60.2K 0.1% 174
2022
Q2 		$1.23M Buy
19,537
+3,384
+21% +$224K 0.09% 189
2022
Q1 		$1.14M Buy
16,153
+1,808
+13% +$122K 0.08% 227
2021
Q4 		$896K Buy
14,345
+1,397
+11% +$87.7K 0.06% 240
2021
Q3 		$799K Sell
12,948
-1,025
-7% -$61.7K 0.06% 255
2021
Q2 		$836K Sell
13,973
-465
-3% -$29.5K 0.06% 242
2021
Q1 		$878K Buy
14,438
+632
+5% +$34.9K 0.08% 212
2020
Q4 		$648K Sell
13,806
-5,226
-27% -$226K 0.06% 235
2020
Q3 		$708K Sell
19,032
-1,038
-5% -$39.4K 0.08% 208
2020
Q2 		$733K Sell
20,070
-1,187
-6% -$41.3K 0.09% 203
2020
Q1 		$650K Sell
21,257
-7,701
-27% -$341K 0.1% 172
2019
Q4 		$1.48M Sell
28,958
-3,190
-10% -$154K 0.19% 124
2019
Q3 		$1.52M Sell
32,148
-7,453
-19% -$355K 0.21% 113
2019
Q2 		$1.97M Sell
39,601
-4,016
-9% -$189K 0.3% 77
2019
Q1 		$1.86M Sell
43,617
-8,302
-16% -$367K 0.3% 90
2018
Q4 		$2.13M Sell
51,919
-3,808
-7% -$163K 0.38% 66
2018
Q3 		$2.6M Hold
55,727
– – 0.43% 67
2018
Q2 		$2.43M Buy
55,727
+1,388
+3% +$64.7K 0.42% 78
2018
Q1 		$2.49M Buy
54,339
+4,978
+10% +$242K 0.46% 70
2017
Q4 		$2.5M Buy
49,361
+2,222
+5% +$117K 0.42% 73
2017
Q3 		$2.45M Sell
47,139
-4,065
-8% -$198K 0.46% 61
2017
Q2 		$2.51M Buy
51,204
+232
+0.5% +$10.8K 0.38% 74
2017
Q1 		$2.4M Buy
50,972
+3,395
+7% +$162K 0.37% 80
2016
Q4 		$2.29M Sell
47,577
-5,591
-11% -$256K 0.4% 65
2016
Q3 		$2.1M Buy
+53,168
New +$2M 0.39% 59

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Corient Capital Partners's MET Position: Q3 2022 in Review

Corient Capital Partners increased its MetLife (MET) stake by 4.8% in Q3 2022, buying an estimated $60.2K and bringing the position to 20,479 shares worth $1.29M. The position accounts for 0.1% of the portfolio, ranked #174.

Corient Capital Partners first reported a position in MET in Q3 2016 and has held it in 25 quarters since. The position peaked at $2.6M in Q3 2018. 1,194 funds tracked by Wall St. Rank hold MET as of Q3 2022.

  • Corient Capital Partners held 20,479 shares of MetLife worth $1.29M as of Q3 2022.
  • Corient Capital Partners bought 942 MetLife shares in Q3 2022, an estimated $60.2K.
  • MetLife made up 0.1% of Corient Capital Partners's portfolio in Q3 2022, its #174 holding.
  • Corient Capital Partners first reported a position in MetLife in Q3 2016 and has held it in 25 quarters since.
  • Corient Capital Partners's MetLife position peaked at $2.6M in Q3 2018.
  • 1,194 funds tracked by Wall St. Rank held MetLife as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.